NCT07741812Not yet recruiting
Testing a Reading Module to Improve Reading Skills and Quality of Life in Glaucoma Patients
Evaluation of The Effectiveness Of Reading Rehabilitation Module On Reading Performance And Quality of Life In Patients With Glaucoma
Source: ClinicalTrials.gov · Last updated 12 Aug 2026
Brief summary (registry, in English)
The goal of this interventional study is to test the effectiveness of reading rehabilitation module towards reading speed and error, and quality of life in glaucoma patients.The main questions it aims to answer are: 1. Is there a significant difference in reading speed over a 6-month period between glaucoma patients who undergo a reading rehabilitation module and those who receive standard care? 2. To what extent does the implementation of a reading rehabilitation module reduce the frequency of reading errors in glaucoma patients compared to a control group across baseline, 3-month, and 6-month follow-ups? 3. How does a structured reading rehabilitation module influence the self-reported quality of life in glaucoma patients from baseline to 6 months when compared to those receiving standard care? Participants will: Patients in interventional group will be instructed to practice the reading module for 20-30 minutes daily, minimum 3 days/week, for 6 months. Visit the clinic once every 3 months for checkups and tests A logbook will be provided to record their practice sessions. While participants in control group will receive standard care, visit the clinic once every 3 months for checkups and tests.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 28 Jul 2026
- Start date
- 1 Sept 2026
- Primary completion date
- 28 Feb 2027
- Lead sponsor
- Universiti Sains Malaysia
- Diseases
- Glaucoma
- NCT number
- NCT07741812
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 1 Sept 2026 to the primary completion date, 28 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of previous intraocular surgery other than uncomplicated cataract within past 6 months.
Other illness
- Other comorbidities that affect memory (e.g., stroke, cognitive disorders).
- Cognitive disorders (e.g., diagnosed dementia or cognitive impairment).
- Poorly controlled diabetes mellitus, hypertension and hyperlipidaemia.
Age
- Ocular diseases other than glaucoma (e.g., age-related macula degeneration, diabetic retinopathy, moderate to severe cataract).
Other
- Other media opacities.
Who the study is looking for
- Age 18- 80 years old.
- Confirmed diagnosis of bilateral Primary Open Angle Glaucoma (POAG),Primary Angle Closure Glaucoma (PACG), Normotensive Glaucoma (NTG) and Juvenile Open Angle Glaucoma (JOAG).
- Bilateral visual acuity of 6/60 and better.
- Bilateral visual field defect more than 10degree from fixation.
- Phakic without visually significant cataract.
- Pseudophakic for more than 3 months prior to recruitment.
- Literate patients.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universiti Sains Malaysia Coordinator of this site? Confirm its status | Kota Bharu | Malaysia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.